Trademark: 88283813
Word
MS WAYBRIGHT
Status
Dead
Status Code
606
Status Date
Monday, August 22, 2022
Serial Number
88283813
Mark Type
4000
Filing Date
Thursday, January 31, 2019
Published for Opposition
Tuesday, May 21, 2019
Abandoned Date
Monday, August 22, 2022

Trademark Owner History
Novartis AG - Owner At Publication

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma
"MS"

Trademark Events
Aug 22, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 22, 2022
Abandonment - No Use Statement Filed
Jan 21, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 20, 2022
Sou Extension 5 Granted
Jan 12, 2022
Sou Extension 5 Filed
Jan 20, 2022
Case Assigned To Intent To Use Paralegal
Jan 12, 2022
Sou Teas Extension Received
Jul 13, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 9, 2021
Sou Extension 4 Granted
Jul 9, 2021
Sou Extension 4 Filed
Jul 9, 2021
Sou Teas Extension Received
Jan 16, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 14, 2021
Sou Extension 3 Granted
Jan 14, 2021
Sou Extension 3 Filed
Jan 14, 2021
Sou Teas Extension Received
Jul 9, 2020
Notice Of Approval Of Extension Request E-Mailed
Jul 7, 2020
Sou Extension 2 Granted
Jul 7, 2020
Sou Extension 2 Filed
Jul 7, 2020
Sou Teas Extension Received
Jan 14, 2020
Notice Of Approval Of Extension Request E-Mailed
Jan 10, 2020
Sou Extension 1 Granted
Jan 10, 2020
Sou Extension 1 Filed
Jan 10, 2020
Sou Teas Extension Received
Jul 16, 2019
Noa E-Mailed - Sou Required From Applicant
May 21, 2019
Official Gazette Publication Confirmation E-Mailed
May 21, 2019
Published For Opposition
May 1, 2019
Notification Of Notice Of Publication E-Mailed
Apr 12, 2019
Assigned To Lie
Mar 20, 2019
Approved For Pub - Principal Register
Mar 20, 2019
Examiner's Amendment Entered
Mar 20, 2019
Notification Of Examiners Amendment E-Mailed
Mar 20, 2019
Examiners Amendment E-Mailed
Mar 20, 2019
Examiners Amendment -Written
Mar 18, 2019
Assigned To Examiner
Feb 22, 2019
New Application Office Supplied Data Entered
Feb 4, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24